|
1
|
Denny L, de Sanjose S, Mutebi M, Anderson
BO, Kim J, Jeronimo J, Herrero R, Yeates K, Ginsburg O and
Sankaranarayanan R: Interventions to close the divide for women
with breast and cervical cancer between low-income and
middle-income countries and high-income countries. Lancet.
389:861–870. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lehmann BD, Bauer JA, Chen X, Sanders ME,
Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human
triple-negative breast cancer subtypes and preclinical models for
selection of targeted therapies. J Clin Invest. 121:2750–2767.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burstein MD, Tsimelzon A, Poage GM,
Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK,
Hilsenbeck SG, Chang JC, et al: Comprehensive genomic analysis
identifies novel subtypes and targets of triple-negative breast
cancer. Clin Cancer Res. 21:1688–1698. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cappato S, Tonachini L, Giacopelli F,
Tirone M, Galietta LJ, Sormani M, Giovenzana A, Spinelli AE,
Canciani B, Brunelli S, et al: High-throughput screening for
modulators of ACVR1 transcription: Discovery of potential
therapeutics for fibrodysplasia ossificans progressiva. Dis Model
Mech. 9:685–696. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang K, Sun X, Feng HL, Fei C and Zhang Y:
DNALK2 inhibits the proliferation and invasiveness of breast cancer
MDA-MB-231 cells through the Smad-dependent pathway. Oncol Rep.
37:879–886. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li L, Liu Y, Guo Y, Liu B, Zhao Y, Li P,
Song F, Zheng H, Yu J, Song T, et al: Regulatory MiR-148a-ACVR1/BMP
circuit defines a cancer stem cell-like aggressive subtype of
hepatocellular carcinoma. Hepatology. 61:574–584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pencheva N and Tavazoie SF: Control of
metastatic progression by microRNA regulatory networks. Nat Cell
Biol. 15:546–554. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pencheva N, Tran H, Buss C, Huh D,
Drobnjak M, Busam K and Tavazoie SF: Convergent multi-miRNA
targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis
and angiogenesis. Cell. 151:1068–1082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jena MK: MicroRNAs in the development and
neoplasia of the mammary gland. F1000 Res. 6:10182017. View Article : Google Scholar
|
|
11
|
Rodriguez-Barrueco R, Nekritz EA, Bertucci
F, Yu J, Sanchez-Garcia F, Zeleke TZ, Gorbatenko A, Birnbaum D,
Ezhkova E, Cordon-Cardo C, et al: miR-424(322)/503 is a breast
cancer tumor suppressor whose loss promotes resistance to
chemotherapy. Genes Dev. 31:553–566. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen Y, Ye YF, Ruan LW, Bao L, Wu MW and
Zhou Y: Inhibition of miR-660-5p expression suppresses tumor
development and metastasis in human breast cancer. Genet Mol Res.
16:2017. View Article : Google Scholar
|
|
13
|
Eom S, Kim Y, Park D, Lee H, Lee YS, Choe
J, Kim YM and Jeoung D: Histone deacetylase-3 mediates positive
feedback relationship between anaphylaxis and tumor metastasis. J
Biol Chem. 289:12126–12144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai YY, Shen F, Cai WS, Chen JW, Feng JH,
Cao J, Xiao HQ, Zhu GH and Xu B: MiR-384 regulated IRS1 expression
and suppressed cell proliferation of human hepatocellular
carcinoma. Tumour Biol. 37:14165–14171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng J, Liu X, Wang P, Xue Y, Ma J, Qu C
and Liu Y: CRNDE promotes malignant progression of glioma by
attenuating miR-384/PIWIL4/STAT3 axis. Mol Ther. 24:1199–1215.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YX, Chen YR, Liu SS, Ye YP, Jiao HL,
Wang SY, Xiao ZY, Wei WT, Qiu JF, Liang L, et al: MiR-384 inhibits
human colorectal cancer metastasis by targeting KRAS and CDC42.
Oncotarget. 7:84826–84838. 2016.PubMed/NCBI
|
|
17
|
Matamala N, Vargas MT, González-Cámpora R,
Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G,
Yanowsky K, Calvete-Candenas J, et al: Tumor microRNA expression
profiling identifies circulating microRNAs for early breast cancer
detection. Clin Chem. 61:1098–1106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye YP, Wu P, Gu CC, Deng DL, Jiao HL, Li
TT, Wang SY, Wang YX, Xiao ZY, Wei WT, et al: miR-450b-5p induced
by oncogenic KRAS is required for colorectal cancer progression.
Oncotarget. 7:61312–61324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi C, Yang Y, Xia Y, Okugawa Y, Yang J,
Liang Y, Chen H, Zhang P, Wang F, Han H, et al: Novel evidence for
an oncogenic role of microRNA-21 in colitis-associated colorectal
cancer. Gut. 65:1470–1481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu M, Huang F, Zhang D, Ju J, Wu XB, Wang
Y, Wang Y, Wu Y, Nie M, Li Z, et al: Heterochromatin protein HP1γ
promotes colorectal cancer progression and is regulated by miR-30a.
Cancer Res. 75:4593–4604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Loo JM, Scherl A, Nguyen A, Man FY,
Weinberg E, Zeng Z, Saltz L, Paty PB and Tavazoie SF: Extracellular
metabolic energetics can promote cancer progression. Cell.
160:393–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Massagué J: TGF-beta signal transduction.
Annu Rev Biochem. 67:753–791. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kamiya N, Kaartinen VM and Mishina Y:
Loss-of-function of ACVR1 in osteoblasts increases bone mass and
activates canonical Wnt signaling through suppression of Wnt
inhibitors SOST and DKK1. Biochem Biophys Res Commun. 414:326–330.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Slattery ML, John EM, Torres-Mejia G,
Herrick JS, Giuliano AR, Baumgartner KB, Hines LM and Wolff RK:
Genetic variation in bone morphogenetic proteins and breast cancer
risk in hispanic and non-hispanic white women: The breast cancer
health disparities study. Int J Cancer. 132:2928–2939. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reed KR, Athineos D, Meniel VS, Wilkins
JA, Ridgway RA, Burke ZD, Muncan V, Clarke AR and Sansom OJ:
B-catenin deficiency, but not Myc deletion, suppresses the
immediate phenotypes of APC loss in the liver. Proc Natl Acad Sci
USA. 105:18919–18923. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arce L, Yokoyama NN and Waterman ML:
Diversity of LEF/TCF action in development and disease. Oncogene.
25:7492–7504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu FI, Sun YH, Wei CY, Thisse C and Thisse
B: Tissue-specific derepression of TCF/LEF controls the activity of
the Wnt/β-catenin pathway. Nat Commun. 5:53682014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamada N, Noguchi S, Mori T, Naoe T, Maruo
K and Akao Y: Tumor-suppressive microRNA-145 targets catenin δ-1 to
regulate Wnt/β-catenin signaling in human colon cancer cells.
Cancer Lett. 335:332–342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou AD, Diao LT, Xu H, Xiao ZD, Li JH,
Zhou H and Qu LH: β-Catenin/LEF1 transactivates the
microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling
pathway. Oncogene. 31:2968–2978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji S, Ye G, Zhang J, Wang L, Wang T, Wang
Z, Zhang T, Wang G, Guo Z, Luo Y, et al: miR-574-5p negatively
regulates Qki6/7 to impact β-catenin/Wnt signalling and the
development of colorectal cancer. Gut. 62:716–726. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
36
|
Malanchi I, Peinado H, Kassen D, Hussenet
T, Metzger D, Chambon P, Huber M, Hohl D, Cano A, Birchmeier W and
Huelsken J: Cutaneous cancer stem cell maintenance is dependent on
betacatenin signalling. Nature. 452:650–653. 2008. View Article : Google Scholar : PubMed/NCBI
|
